New York CPH APS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 4.9% 28.5% 12.9% 9.9%  
Credit score (0-100)  0 46 2 17 24  
Credit rating  N/A BBB B BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  0.0 3,676 8,680 9,466 6,902  
EBITDA  0.0 704 -649 624 495  
EBIT  0.0 522 -804 391 425  
Pre-tax profit (PTP)  0.0 521.5 -805.2 388.6 424.7  
Net earnings  0.0 406.8 -805.2 299.7 346.7  
Pre-tax profit without non-rec. items  0.0 522 -805 389 425  

 
See the entire income statement

Balance sheet (kDKK) 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  0.0 547 466 1,301 1,231  
Shareholders equity total  0.0 447 -358 -58.7 366  
Interest-bearing liabilities  0.0 35.1 0.0 23.9 0.0  
Balance sheet total (assets)  0.0 1,552 2,927 4,272 4,463  

Net Debt  0.0 -120 -46.8 -288 -220  
 
See the entire balance sheet

Volume 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 3,676 8,680 9,466 6,902  
Gross profit growth  0.0% 0.0% 136.1% 9.0% -27.1%  
Employees  0 23 29 0 61  
Employee growth %  0.0% 0.0% 26.1% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 1,552 2,927 4,272 4,463  
Balance sheet change%  0.0% 0.0% 88.6% 46.0% 4.5%  
Added value  0.0 703.9 -648.8 546.1 494.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 365 -236 602 -140  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 -1.0 1.0 2.0  

Profitability 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 14.2% -9.3% 4.1% 6.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 33.6% -33.2% 10.3% 9.7%  
ROI %  0.0% 108.2% -333.7% 1,371.0% 200.8%  
ROE %  0.0% 91.0% -47.7% 8.3% 14.9%  

Solidity 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  0.0% 28.8% -10.9% -1.4% 8.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -17.0% 7.2% -46.2% -44.6%  
Gearing %  0.0% 7.9% 0.0% -40.7% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 6.0% 17.7% 0.0%  

Liquidity 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  0.0 0.8 0.0 0.1 0.1  
Current Ratio  0.0 0.8 0.7 0.5 0.6  
Cash and cash equivalent  0.0 155.0 46.8 312.1 220.5  

Capital use efficiency 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -260.4 -984.5 -1,936.7 -1,475.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 31 -22 0 8  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 31 -22 0 8  
EBIT / employee  0 23 -28 0 7  
Net earnings / employee  0 18 -28 0 6